Add-on treatment with pyridoxine and sulthiame in 12 infants with West syndrome: An open clinical study

Seizure

Volumn 11, Issue 6, 2002, Pages 381-383

  Debus, Otfried Martin ^a   Köhring, Jessika ^a   Fiedler, Barbara ^a   Franssen, Maike ^a   Kurlemann, Gerhard ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Add on therapy; Pyridoxine; Sulthiame; West syndrome

Indexed keywords

ANTICONVULSIVE AGENT; CLOBAZAM; CORTICOTROPIN; DEXAMETHASONE; LAMOTRIGINE; PHENOBARBITAL; PYRIDOXINE; SULTIAME; VALPROIC ACID; VIGABATRIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEX PARTIAL SEIZURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; GASTROINTESTINAL TOXICITY; HUMAN; HYPSARRHYTHMIA; INFANT; MALE; MONOTHERAPY; PRIORITY JOURNAL; SEIZURE; SIDE EFFECT; WEST SYNDROME;

EID: 0036747358     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1053/seiz.2001.0667     Document Type: Article

References (14)

1. Klein, R. and Livingston, S. The effect of adrenocorticotrophic hormone in epilepsy. Journal of Pediatrics 1950; 37: 733-742.
2. Snead, O. C. and Chiron, C. Medical Treatment. In: Infantile spasms and West syndrome. (Eds O. Dulac, H. A. T. Chugani and B. Dalla Bernadina). London, Philadelphia, Toronto, Sydney and Tokyo, W.B. Saunders Company Ltd., 1994: pp. 245-251.
3. Ohtsuka, Y., Murashima, I., Oka, E. and Ohtahara, S. Treatment and prognosis of West syndrome. Journal of Epilepsy 1994; 7: 279-284.
4. Riikonen, R. and Donner, M. ACTH therapy in infantile spasms: side effects. Archives of Disease in Childhood 1980; 55: 664-672.
5. Siemes, H., Spohr, H. L., Michael, T. and Nau, H. Therapy of infantile spasms with valproate: results of a prospective study. Epilepsia 1988; 29: 553-560.
6. Glauser, T. A., Clark, P. O. and McGee, K. Long-term response to topiramate in patients with West syndrome. Epilepsia 2000; 41 (Suppl. 1): 91-94.
7. Vivegano, F. and Cilio, M. R. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study. Epilepsia 1997; 38: 1270-1274.
8. Fejerman, N., Cers-simo, R., Caraballo, R. et al. Vigabatrin as a first-choice drug in the treatment of West syndrome. Journal of Child Neurology 2000; 15: 161-165.
9. Ohtsuka, Y., Matsuda, M., Ogino, T., Kobayashi, K. and Ohtahara, S. Treatment of the West syndrome with high-dose pyridoxal phosphate. Brain and Development 1987; 9: 418-421.
10. Pietz, J., Benninger, C., Schäfer, H., Sontheimer, D., Mittermaier, G. and Rating, D. Treatment of infantile spasms with high-dosage vitamin B6. Epilepsia 1993; 34: 757-763.
11. Rho, J. M. and Sankar, R. The pharmacological basis of antiepileptic drug action. Epilepsia 1999; 40: 1476-1477.
12. Rating, D., Wolf, C. and Bast, T. Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: a six-month randomized, double-blind, placebo-controlled study. Epilepsia 2000; 41: 1284-1288.
13. Browne, T. R. and Ascanape, J. S. In: Epilepsy: A Comprehensive Textbook: Diones, Paraldehyde, Phenacemide, Bromides and Sulthiame. (Eds J. Engel and T. A. Pedley). Philadelphia, Lippincott-Raven Publishers, 1997: pp. 1527-1544.
14. Schlumberger, E. and Dulac, O. A simple, effective and well tolerated treatment regimen for West syndrome. Developmental Medicine and Child Neurology 1994; 36: 863-872.